Movano EBITDA Margin 2020-2024 | MOVE
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Movano (MOVE) over the last 10 years. The current EBITDA margin for Movano as of December 31, 2024 is .
| Movano EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $0.00B | $-0.02B | -2400.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.005B | $0.001B |
| Movano Inc. is a health technology company. It engages in designing devices which empower individuals to optimize their health in order to prevent and better manage chronic diseases. Movano Inc. is based in PLEASANTON, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.644B | 58.07 |
| Doximity (DOCS) | United States | $11.655B | 53.96 |
| Hims & Hers Health (HIMS) | United States | $11.295B | 117.35 |
| Tempus AI (TEM) | United States | $9.675B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.275B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.775B | 58.99 |
| Hinge Health (HNGE) | United States | $3.572B | 0.00 |
| Privia Health (PRVA) | United States | $2.516B | 172.00 |
| Enovis (ENOV) | United States | $1.765B | 9.84 |
| Phreesia (PHR) | United States | $1.591B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.517B | 0.00 |
| 10x Genomics (TXG) | United States | $1.505B | 0.00 |
| Schrodinger (SDGR) | United States | $1.495B | 0.00 |
| Azenta (AZTA) | United States | $1.461B | 67.89 |
| Evolent Health (EVH) | United States | $1.335B | 113.70 |
| Omnicell (OMCL) | United States | $1.276B | 22.51 |
| Claritev (CTEV) | United States | $0.717B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.435B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.321B | 713.00 |
| Outset Medical (OM) | United States | $0.320B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.270B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.213B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| American Well (AMWL) | United States | $0.125B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.120B | 0.00 |
| Pulmonx (LUNG) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.080B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |